Literature DB >> 16357812

Pre-diabetes essential action: a European perspective.

P Valensi1, E H Schwarz, M Hall, A M Felton, A Maldonato, C Mathieu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16357812     DOI： 10.1016/s1262-3636(07)70239-2

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  11 in total

1.  Development of a diabetes prevention management program for clinical practice.

Authors:  Peter E H Schwarz; Jaqueline Schwarz; Andrea Schuppenies; Stefan R Bornstein; Jan Schulze
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

2.  Drugs for pre-osteoporosis: prevention or disease mongering?

Authors:  Pablo Alonso-Coello; Alberto López García-Franco; Gordon Guyatt; Ray Moynihan
Journal:  BMJ       Date:  2008-01-19

3.  Wound bed preparation and oxygen balance--a new component?

Authors:  R Gary Sibbald; Kevin Y Woo; Douglas Queen
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

Review 4.  How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?

Authors:  Peter E H Schwarz; Jiang Li; Jaana Lindström; Antje Bergmann; Ulrike Gruhl; Timo Saaristo; Jaakko Tuomilehto
Journal:  Curr Diab Rep       Date:  2007-10       Impact factor: 4.810

5.  Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.

Authors:  Zhen Wang; Hong Zhang; Xu-Hui Shen; Kui-Li Jin; Guo-Fen Ye; Wei Qiu; Li Qian; Bo Li; Yong-Hong Zhang; Guo-Ping Shi
Journal:  Ann Med       Date:  2012-10-30       Impact factor: 4.709

Review 6.  Who should we target for diabetes prevention and diabetes risk reduction?

Authors:  Susann Blüher; Jana Markert; Sabine Herget; Thomas Yates; Melanie Davis; Gabriele Müller; Thomas Waldow; Peter E H Schwarz
Journal:  Curr Diab Rep       Date:  2012-04       Impact factor: 4.810

Review 7.  A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals.

Authors:  R R Simon; V Marks; A R Leeds; J W Anderson
Journal:  Diabetes Metab Res Rev       Date:  2010-12-07       Impact factor: 4.876

8.  Adiponectin is Associated with Impaired Fasting Glucose in the Non-Diabetic Population.

Authors:  Sang Yeun Kim; Sun Ju Lee; Hyoun Kyoung Park; Ji Eun Yun; Myoungsook Lee; Jidong Sung; Sun Ha Jee
Journal:  Epidemiol Health       Date:  2011-08-20

9.  Diabetes prevention: a call to action.

Authors:  Tom Yates; Melanie J Davies; Peter E H Schwarz; Kamlesh Khunti
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

10.  Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study.

Authors:  B Bendinelli; D Palli; G Masala; S J Sharp; M B Schulze; M Guevara; A D L van der; F Sera; P Amiano; B Balkau; A Barricarte; H Boeing; F L Crowe; C C Dahm; G Dalmeijer; B de Lauzon-Guillain; R Egeberg; G Fagherazzi; P W Franks; V Krogh; J M Huerta; P Jakszyn; K T Khaw; K Li; A Mattiello; P M Nilsson; K Overvad; F Ricceri; O Rolandsson; M J Sánchez; N Slimani; I Sluijs; A M W Spijkerman; B Teucher; A Tjonneland; R Tumino; S W van den Berg; N G Forouhi; C Langeberg; E J M Feskens; E Riboli; N J Wareham
Journal:  Diabetologia       Date:  2012-09-16       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.